DGAP-News: Biogas Nord AG: Publication of 2012 consolidated

Biogas Nord AG / Key word(s): Miscellaneous 31.07.2013 20:25 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer / publisher is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Biogas Nord AG - Publication of 2012 consolidated financial statements postponed - 2012: significant decline in turnover, net loss for the year in low seven-figure range - Restructuring programme negatively affects profit for 2013 Bielefeld, 31 July 2013. Biogas Nord AG, one of the leading providers of innovative and customised energy solutions in the field of biogas technology, is postponing the publication of its business figures for 2012 until the end of September 2013 and implementing a restructuring programme. As part of the compilation of consolidated financial statements under IFRS for the first time in 2012 and the changes to the Management Board at the beginning of July 2013, a range of issues have once again been subject to detailed review. In addition to the time-consuming work involved in conducting this process, circumstances have been discovered that will now undergo separate examination. Accordingly, publication of the 2012 consolidated financial statements has been postponed and is now anticipated at the end of September 2013. Deutsche Börse AG has already been informed of this situation. In comparison with 2011, the 2012 consolidated financial statements will exhibit a significant decline in turnover alongside a net loss in the low seven-figure euro range. In response to the figures, a decision was made to implement a restructuring programme based on six pillars. The reorganisation will affect the entire Group. The restructuring will focus on reporting, process management, the Finance and Controlling department, Sales and the Project Handling department. In addition to considerable cost savings thanks to a streamlined corporate structure, the primary objectives are greater profitability, marked improvement in process handling in all departments and an enhanced financial structure. Despite the current large order backlog of approximately EUR 80 million, a net loss is expected again in 2013 owing to non-recurring effects. About Biogas Nord Biogas Nord is a global company building turn-key biogas plants all over the world. Established in the year 2000 and headquartered in Bielefeld, Germany, Biogas Nord has constructed to date more than 390 biogas plants worldwide, in Germany, Belgium, the Czech Republic, the Netherlands, the USA, Italy, the UK, Belarus, Ireland, Thailand, Cuba, Romania and Latvia, France, Poland and Slovakia. The company provides solutions in all areas of biogas technology starting with concept development, operation and feasibility analysis, detailed design and planning, provision of approvals and licenses, construction and commissioning, and finally operation, management, and service and maintenance. Biogas Nord's sophisticated plant technology has proven itself throughout the years as durable, flexible and reliable. Its concepts are always adapted to local conditions and coupled with optimized use of efficient, high-grade components. Optimal operating results are achieved by a fermentation technology designed for flexible substrate selection combined with low operating costs and a high gas yield. Further efficiency increases for each plant are achieved through the integration of a heat recovery system. Biogas Nord is a public company, traded on the Frankfurt Stock Exchange since November 2006. It is operating in Germany through its subsidiary Biogas Nord Anlagenbau GmbH, in Spain through Biogas Nord España S.L., in Italy through Biogas Nord Italia S.R.L., in Poland through Biogas Nord Polska Sp. z o. o., in France through Biogas Nord SAS, and in the UK through Biogas Nord UK Ltd. and in Korea through Biogas Nord Korea Ltd. Contact: Biogas Nord AG Werningshof 2�4 D�33719 Bielefeld Tel. +49 (0)521 � 96 33 � 0 info@biogas.de www.biogas.de Investor Relations contact: GFEI Aktiengesellschaft Am Hauptbahnhof 6 D�60329 Frankfurt Tel. +49 (0)69 � 74 30 37 � 00 biogasnord@gfei.de www.gfei.de Disclaimer: This Corporate News is intended solely for informational purposes and does not constitute a solicitation to buy, hold or sell securities. This Corporate News may contain forward�looking statements. Forward�looking statements are statements that are not historical facts. They include statements about our beliefs and expectations. These statements relate to the current plans, estimates and forecasts currently available to the BIOGAS NORD AG management. Forward�looking statements therefore only apply on the day they were made. By their nature, forward�looking statements harbor risks and possible uncertainties. Various known and unknown risks, uncertainties and other factors could mean that the actual results, the financial situation, the development or the performance of the company greatly differs from the estimations published here. These factors include those described by BIOGAS NORD AG in its published reports. These reports are available on the BIOGAS NORD website at www.biogas.de We assume no liability whatsoever to update these forward�looking statements or to adjust them in line with future events or developments. 31.07.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Biogas Nord AG Werningshof 2-4 33719 Bielefeld Germany Phone: +49 (0)521 557 507 - 0 Fax: +49 (0)521 557 507 - 33 E-mail: info@biogas.de Internet: www.biogas.de ISIN: DE000A0HHE20 WKN: A0HHE2 Listed: Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard) End of Announcement DGAP News-Service ---------------------------------------------------------------------------